Pre-earnings options volume in LifeMD (LFMD) is 5.6x normal with calls leading puts 22:1. Implied volatility suggests the market is ...

Craig-Hallum analyst Alex Fuhrman maintained a Buy rating on LifeMD (LFMD – Research Report) today. The company’s shares closed last Friday at ...

在该公司发布的最新财报中，公司每股收益为$0.21，总营收为$64.3M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$57.66M，每股收益为$-0.05.

LifeMD (NASDAQ:LFMD) is scheduled to announce Q4 earnings results on Monday, March 10th, after market close. The consensus EPS Estimate is $0.14 (-6.7% Y/Y) and the consensus Revenue Estimate is ...

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq ...

The "U.S. Medical Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering. This report presents a complete picture of the medical weight loss market in the ...